Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
An **immune complex** is a molecular structure formed when an antibody binds to an antigen, typically IgG or IgM classes interacting with foreign or self-antigens[1][5][3]. Immune complexes facilitate pathogen clearance and activation of immune cells via Fc and complement receptors, but may become pathogenic if deposited in tissues—leading to inflammation, tissue injury, and diseases such as vasculitis, rheumatoid arthritis, and systemic lupus erythematosus[3][6]. Immune complex formation is a central mechanism in type III hypersensitivity reactions, and their detection aids in the diagnosis and management of various immune-mediated diseases[1][5]. Further context: - **Is_target / is_incorrect**: Immune complexes themselves are not a drug target in the sense of being a molecular entity such as a receptor, enzyme, or transporter; instead, they are products of antibody-antigen binding, involved in disease mechanisms but not a canonical molecular target. Therapies may focus on clearing or reducing immune complexes, but the complexes are not a **specific molecule or receptor**[1][3]. - **Aliases**: "Immune complex" is generally preferred in the singular form for nomenclature consistency. - **Molecular classification**: Immune complexes are not proteins, receptors, or enzymes, but aggregated molecular structures formed by antibodies bound to antigens. - **Therapeutic context**: While drug therapies can modify the formation or effects of immune complexes (immunosuppressives, biologics, plasmapheresis), immune complexes themselves are not the direct pharmacological target in the conventional sense, but pivotal mediators in immune-related diseases[1][4][6]. If you require structured information for a canonical molecular target, such as an Fc receptor or complement protein (e.g., Fc gamma receptor, C5a receptor), please specify.
Removal or clearance of immune complexes from circulation; Suppression of immune complex formation or deposition; Inhibition of complement activation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune complex (null).